The largest database of trusted experimental protocols

3 protocols using anti il 10 bv421

1

Immunophenotyping of B Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescence-activated cell sorting analysis was performed using a BD LSRFortessa™ (BD Biosciences, San Jose, CA). The following antibodies were used to classify cells: anti-CD19-fluorescein isothiocyanate (FITC) (Miltenyi Biotec, Friedrich Gladbach, Germany), anti-CD3-allophycocyanin (APC), anti-CD4-APC, anti-CD4-phycoerythrin (PE), anti-CD24-peridinin chlorophyll protein complex-Cy 5.5 (PerCP Cy5.5), anti-CD25-APC, anti-CD27-PE, anti-CD39- brilliant violet 421 (BV421), anti-CD45-V500, anti-CD73-APC, anti-IFN-γ-BV421, and anti-IL-10-BV421 (all from BD PharMingen, Franklin Lakes, NJ), anti-CD80-APC, anti-CD86-APC monoclonal antibody (mAb) (Biolegend, San Diego, CA), Annexin V- FITC (BD PharMingen), and DAPI (Cell Biolabs, San Diego, CA). The CD19+CD24hiCD27+ B cell subset was sorted using a Moflo XDP cell sorter (Beckman Coulter, Brea, CA) with 90% to 95% purities.
+ Open protocol
+ Expand
2

Cytokine Expression in Acute Hepatitis E

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of cytokines IL-10 and TGF-β by B cells and its subsets were assessed by intracellular cytokine staining. PBMCs from 36 acute hepatitis E patients, 29 hepatitis E recovered individuals and 51 healthy controls were incubated with 1 μM CpG-B ODN2006 (InvivoGen, CA, USA) for 72 h at 37°C. Phorbol myristate acetate (PMA) (25 ng/mL) and ionomycin (1 μg/mL) (Sigma, USA) were added in the last 5 h in the presence of 10 μg/mL Brefeldin-A (Sigma, USA). Alternatively, PBMCs were stimulated with HEV-rORF2p (10 μg/mL) for 72 h. Cells were then surface stained for the markers CD19 PE-Cy7, CD24 PE and CD38 FITC (BD Biosciences, CA, USA), fixed, permeabilized, and stained intracellularly with anti-IL-10 BV421 and TGF-β PerCP-Cy5.5 antibodies (BD Biosciences, CA, USA). Isotype and Fluorescence Minus One (FMO) controls were used in all sets of experiments. For each sample, 50,000 events were acquired in BD FACS Aria-II flow cytometer and data were analyzed using BD FACS Diva software (BD Biosciences, CA, USA). Data from stimulated cells were analyzed after normalization with unstimulated cells. The gating strategy is depicted in (Supplementary Figure S2).
+ Open protocol
+ Expand
3

Phenotypic Analysis of Activated T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (10 7 /ml) were plated and incubated at 37°C in an atmosphere of 5% CO 2 for 5 h in RPMI-1640 (Sigma-Aldrich, Steinheim, Germany) with penicillin-streptomycin (Sigma-Aldrich), L-glutamine (Sigma-Aldrich), and foetal bovine serum (Sigma-Aldrich) in the presence of 50 ng/ml phorbol 12-myrisate 13-acetate (Sigma-Aldrich), 250 ng/ml ionomycin (Sigma-Aldrich), and 2 μg/ml monensin (Sigma-Aldrich). Thereafter, the cells were immediately stained with the following antibodies from BD Biosciences: anti-CD3-BV650 (563852), anti-CD4-AF700 (557922), and anti-CD8-APC-H7 (560179). Next, they were fixed and permeabilized according to the manufacturer's protocol (Permeabilization Buffer 00-8333-56, Fixation/Permeabilization Diluent 00-5223-56, and Fixation/Permeabilization Concentrate 00-5123-43; eBioscience, San Diego, CA, USA). Finally, the cells were stained with the following antibodies: anti-IL5-PE (554395; BD Biosciences), anti-IL10-BV421 (564053; BD Biosciences), anti-IL17-BV510 (563295; BD Biosciences), anti-IL22-PerCP eFluor (710 46-7229-42; eBioscience), and anti-interferon (IFN)-γ-BV488 (557718; BD Biosciences). Brilliant Stain Buffer was added to the antibody cocktail.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!